pharmaphorum

FEBRUARY 29, 2024

Palatin Technologies’ therapy for dry eye disease (DED) missed its primary endpoints in a phase 3 trial, knocking investor confidence as it tries to chart a way forward.

98

98

Drug Topics

FEBRUARY 21, 2024

How much longer can independent pharmacists survive with the current method of reimbursement?

275

275

STAT

NOVEMBER 9, 2023

NEW YORK — Surgeons have performed the world’s first transplant of an entire human eye, an extraordinary addition to a face transplant — although it’s far too soon to know if the man will ever see through his new left eye. His right eye still works. Read the rest…

130

130

Pharmacy Times

APRIL 7, 2023

Eye drops come in many forms and for many indications, such as redness, itchiness, dryness, allergies, dilating drops, glaucoma drops, lubricants, numbing agents, antibiotics, and to lower pressure.

123

123

Drug Store News

OCTOBER 30, 2023

Murad’s new Retinal ReSculpt Eye Treatment works to reduce the appearance of deep-set lines and wrinkles by visibly lifting and firming the under eye area.

105

105

Fierce Healthcare

APRIL 5, 2024

Payer Roundup—Blue Cross Blue Shield Association lawsuit unfolds; Rightway raises $109M; Surescripts reportedly eyes sale ntong Fri, 04/05/2024 - 16:02

105

105

Pharmacy Times

NOVEMBER 9, 2023

Perfluorohexyloctane is the first and only treatment that targets tear evaporation to provide relief for dry eye disease

145

145

Drug Topics

JUNE 26, 2023

Over 37 million people in the United States have diabetes and are at risk for eye disease, with diabetic retinopathy (DR) being the leading cause of blindness in working-age adults.

98

98

Drug Store News

JUNE 23, 2023

Zeiss Warm Eye Masks can be a solution for dry eyes, excessive screen use, airborne pollution or air conditioning, the company said.

98

98

Pharmacy Times

NOVEMBER 3, 2022

Teprotumumab is the first fully human IgG1 monoclonal antibody approved by the FDA for the treatment of thyroid eye disease at its source not just reducing the symptoms.

FDA 122

FDA 122

STAT

SEPTEMBER 28, 2023

Ophthalmologists who accepted payments from drug companies were less likely to prescribe a cheaper medicine to treat an eye disease that causes blindness in older people, rather than a pair of more expensive alternatives, according to a new study. This led Medicare to spend an additional $643 million during a recent six-year period.

Insurance 119

Insurance 119

Pharmacy Times

MAY 19, 2023

The approval marks the first and only FDA-approved treatment for dry eye disease that directly targets tear evaporation.

FDA 132

FDA 132

Pharmaceutical Technology

OCTOBER 30, 2023

The US FDA has issued a warning against the use of 26 over-the-counter eye drop products due to potential eye infection risks.

FDA 98

FDA 98

Fierce Pharma

FEBRUARY 28, 2024

After a busy 2023 marked by multiple drug approvals, UCB isn’t resting on its laurels. After an initial FDA approval came later than anticipated, UCB is looking to quickly grow Bimzelx. The company is eying four new indications and potential peak sales of 4 billion euros.

FDA 96

FDA 96

pharmaphorum

NOVEMBER 7, 2023

CARGO eyes $300m IPO against lacklustre listings backdrop Phil.Taylor Tue, 07/11/2023 - 12:16 Bookmark this

103

103

Pharmaceutical Technology

JUNE 9, 2023

to treat the signs and symptoms of dry eye disease. It has been designed to address the unmet needs of patients and to provide quick action and well-tolerated dry eye drug therapy. The safety and efficacy of VEVYE were assessed in a total of 1,369 patients with dry eye disease, of which 738 received VEVYE.

FDA 98

FDA 98

Drug Topics

DECEMBER 27, 2022

According to the company, clinical outcomes for 78 dry eye patients treated at a single center, the Cleveland Eye Clinic, showcased the duration of efficacy of a single, first-time treatment of MGD using the TearCare System.

98

98

pharmaphorum

SEPTEMBER 28, 2023

Virgin Pulse eyes $3bn merger with HealthComp Phil.Taylor Thu, 28/09/2023 - 10:55 Bookmark this

102

102

Pharmaceutical Technology

APRIL 17, 2024

Discover Unity Biotechnology's groundbreaking method using small molecule drugs to target senescent cells in the eye, reversing age-related conditions. A newly granted patent reveals a unique approach to promoting vascular repair in the eye, offering hope for those with ophthalmic conditions.

52

52

STAT

APRIL 2, 2024

A drug being developed by a Roivant subsidiary for a range of autoimmune conditions succeeded in a mid-stage trial in an eye disease that can ultimately lead to blindness, Roivant said Tuesday. Roivant, which has been flush with cash since selling a drug candidate to Roche last year for $7.1 billion stock buyback initiative.

Compounding 106

Compounding 106

Druggist

APRIL 6, 2021

Patients who have Lacri-Lube eye ointment on their ‘repeats’ should contact their surgery and ask to remove it and replace it with Lacri-lube alternative eye ointments. I will list in this post the best Lacri-Lube alternative eye ointments and gels. Three main active ingredients found in Lacri-lube eye ointment: .

93

93

pharmaphorum

SEPTEMBER 29, 2023

MSD eyes March FDA decision on PAH drug sotatercept Phil.Taylor Fri, 29/09/2023 - 10:21 Bookmark this

FDA 109

FDA 109

pharmaphorum

OCTOBER 5, 2023

Moderna eyes 2025 approval for COVID, flu combination jab Phil.Taylor Thu, 05/10/2023 - 08:38 Bookmark this

104

104

Roots Analysis

NOVEMBER 11, 2023

This concerning development has been traced back to the utilization of EzriCare Artificial Tears Eye Drops. Background Behind EzriCare’s Recall Currently, there have been 81 reported adverse events across 18 states, encompassing eye infections, permanent vision loss, and, regrettably, fatalities.

FDA 52

FDA 52

STAT

MAY 16, 2023

Advancement in the science of eye care over the past 10 years has led to dramatically better outcomes for many people with impaired vision. Anti-VEGFs, which are injected into the eye, slow the growth of blood vessels that often lead to wet AMD, one of the leading causes of blindness in the world. Read the rest…

100

100

pharmaphorum

AUGUST 30, 2023

Outlook slumps as FDA rejects eye disease drug Phil.Taylor Wed, 30/08/2023 - 16:47 Bookmark this

FDA 106

FDA 106

Fierce Pharma

JULY 17, 2023

Apellis Pharmaceuticals' Syfovre, after achieving the first FDA approval for advanced eye disease geographic atrophy, has been associated with rare but severe side effects, according to the America | The American Society of Retinal Specialists sent out a note to doctors on Saturday warning of eye inflammation cases in patients who took Syfovre, (..)

FDA 97

FDA 97

Fierce Pharma

FEBRUARY 1, 2024

Despite a sharp decline in COVID-related sales, the company was able to grow overall revenues thanks in large part to the performance of eye disease drug Vabysmo.

102

102

Fierce Pharma

JULY 27, 2023

To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” | To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.”

FDA 98

FDA 98

Fierce Pharma

MAY 19, 2023

Bausch + Lomb bags FDA approval for dry eye disease treatment Miebo zbecker Fri, 05/19/2023 - 09:39

FDA 130

FDA 130

STAT

SEPTEMBER 21, 2023

The winners of the 2023 awards, announced on Thursday in New York, distinguished themselves in AI-enabled protein modeling, groundbreaking eye test technology, and in a wide-ranging career in medical science that combined innovative discoveries with attention to mentorship and leadership. Read the rest…

108

108

Fierce Pharma

SEPTEMBER 12, 2023

Eight companies are finding themselves in hot water for allegedly churning out illicit eye drugs, the FDA said Tuesday. | The companies included in the warning letter sweep are: Boiron, CVS Health, DR Vitamin Solutions, Natural Ophthalmics, OcluMed, Similasan, TRP Company and Walgreens Boots Alliance.

FDA 102

FDA 102

STAT

FEBRUARY 2, 2023

health officials are advising people to stop using over-the-counter eye drops that have been linked to an outbreak of drug-resistant infections. NEW YORK — U.S. The Centers for Disease Control and Prevention on Wednesday night sent a health alert to physicians, saying the outbreak includes at least 55 people in 12 states.

111

111

pharmaphorum

JUNE 28, 2023

AbbVie, Genmab eye label expansion for Epkinly Phil.Taylor Wed, 28/06/2023 - 13:04 Bookmark this

Labelling 98

Labelling 98

pharmaphorum

JUNE 13, 2023

Almirall eyes pipeline expansion with €200m funding Phil.Taylor Tue, 13/06/2023 - 10:19 Bookmark this

96

96

PharmaShots

MAY 12, 2023

Our eyes are essential for daily life, and any infection can cause discomfort and potentially damage our vision. Eye infections occur due to various causes, including bacteria, viruses, and fungi. Some of the common types of eye infections include conjunctivitis, keratitis, and endophthalmitis.

Immunization 45

Immunization Hospitals 45

Hospital Pharmacy Europe

NOVEMBER 30, 2023

Carbomer-containing eye gels branded Aacarb, Aacomer and Puroptics have a potential risk of microbial contamination, the Medicines and Healthcare products Regulatory Agency (MHRA) has warned. The post Withdrawal notice for carbomer eye gels issued by MHRA over infection fears appeared first on Hospital Pharmacy Europe.

Hospitals 52

Hospitals 52